Vicarious Surgical Inc.: Form 10-Q/A for the period ended Sep 30, 2021
Filed with the SEC on Mar 31, 2022 and accepted by EDGAR at Mar 31, 2022, 16:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2021-07-01 to 2021-09-30 | $5.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-01-01 to 2021-09-30 | $12.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | −$8.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | −$20.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $31.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2021-01-01 to 2021-09-30 | $59.0k | us-gaap:InterestExpense |
| Net income | 9 months2021-01-01 to 2021-09-30 | −$57.0m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2021-07-01 to 2021-09-30 | 92,233,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-01-01 to 2021-09-30 | 89,211,046 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | −$23.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-09-30 | $422.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2021-09-30 | $191.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $193.4m | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $3.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $135.1m | us-gaap:Liabilities |
| Long-term debt | At period end2021-09-30 | $836.0k | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2021-09-30 | $58.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-22-016774. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.